Role of HCN4 channel in preventing ventricular arrhythmia

Journal of Human Genetics

Volumn 54, Issue 2, 2009, Pages 115-121

  Ueda, Kazuo ^a   Hirano, Yuji ^a   Higashiuesato, Yasushi ^b   Aizawa, Yoshiyasu ^a   Hayashi, Takeharu ^a   Inagaki, Natsuko ^a   Tana, Takeshi ^b   Ohya, Yusuke ^b   Takishita, Shuichi ^b   Muratani, Hiromi ^b,c   Hiraoka, Masayasu ^a   Kimura, Akinori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c KYUSHU SANGYO UNIVERSITY   (Japan)

Author keywords

Bradycardia; Computer simulation; HCN4; Mutation; Ventricular arrhythmias

Indexed keywords

ION CHANNEL; PROTEIN HCN4; UNCLASSIFIED DRUG; CYCLIC NUCLEOTIDE GATED CHANNEL; HCN4 PROTEIN, HUMAN; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL; MUSCLE PROTEIN; POTASSIUM CHANNEL;

ACTION POTENTIAL; ARTICLE; BRADYCARDIA; COMPUTER SIMULATION; CONTROLLED STUDY; GENE MUTATION; HEART ARRHYTHMIA; HEART DEPOLARIZATION; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MODEL; CHANNEL GATING; GENETICS; HEART VENTRICLE; MOLECULAR GENETICS; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; RNA SPLICING;

ACTION POTENTIALS; ARRHYTHMIAS, CARDIAC; BASE SEQUENCE; COMPUTER SIMULATION; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; HEART VENTRICLES; HUMANS; HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS; ION CHANNEL GATING; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUTATION; POTASSIUM CHANNELS; RNA SPLICING;

EID: 60749121565     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1038/jhg.2008.16     Document Type: Article

References (30)

1. Ueda, K., Nakamura, K., Hayashi, T., Inagaki, N., Takahashi, M., Arimura, T. et al. Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia. J. Biol. Chem. 279, 27194-27198 (2004).
2. Schulze-Bahr, E., Neu, A., Friederich, P., Kaupp, UB., Breithardt, G., Pongs, O. et al. Pacemaker channel dysfunction in a patient with sinus node disease. J. Clin. Invest. 111, 1537-1545 (2003).
3. Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J. et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12, 17-23 (1996).
4. Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D. & Keating, M. T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795-803 (1995).
5. Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J. L. et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80, 805-811 (1995).
6. Splawski, I., Tristani-Firouzi, M., Lehmann, M. H., Sanguinetti, M. C. & Keating, M. T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat. Genet. 17, 338-340 (1996).
7. Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W. et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97, 175-187 (1997).
8. Tristani-Firouzi, M., Jensen, J. L., Donaldson, M. R., Sansone, V., Meola, G., Hahn, A. et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J. Clin. Invest. 110, 381-388 (2002).
9. Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R. et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31 (2004).
10. Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M. et al. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109, 30-35 (2004).
11. Bellocq, C., van Ginneken, A. C., Bezzina, C. R., Alders, M., Escande, D., Mannens, M. M. et al. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109, 2394-2397 (2004).
12. Chen, Y. H., Xu, S. J., Bendahhou, S., Wang, X. L., Wang, Y., Xu, W. Y. et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299, 251-254 (2003).
13. Yang, Y., Xia, M., Jin, Q., Bendahhou, S., Shi, J., Chen, Y. et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am. J. Hum. Genet. 75, 899-905 (2004).
14. Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392, 293-296 (1998).
15. Schott, J. J., Alshinawi, C., Kyndt, F., Probst, V., Hoorntje, T. M., Hulsbeek, M. et al. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 23, 20-21 (1999).
16. Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R. et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196-200 (2001).
17. Marban, E. Cardiac channelopathies. Nature 415, 213-218 (2002).
18. Moosmang, S., Stieber, J., Zong, X., Biel, M., Hofmann, F. & Ludwig, A. Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues. Eur. J. Biochem. 268, 1646-1652 (2001).
19. Westenskow, P., Splawski, I., Timothy, K. W., Keating, M. T. & Sanguinetti, M. C. Compound mutations: a common cause of severe long-QT syndrome. Circulation 109, 1834-1841 (2004).
20. Nishi, H., Kimura, A., Harada, H., Toshima, H. & Sasazuki, T. Novel missense mutation in cardiac beta myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 188, 379-387 (1992).
21. Wang, Q., Li, Z., Shen, J. & Keating, M. T. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 34, 9-16 (1996).
22. Splawski, I., Shen, J., Timothy, K. W., Vincent, G. M., Lehmann, M. H. & Keating, M. T. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics 51, 86-97 (1998).
23. Plaster, N. M., Tawil, R., Tristani-Firouzi, M., Canun, S., Bendahhou, S., Tsunoda, A. et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105, 511-519 (2001).
24. Chen, J., Mitcheson, J. S., Tristani-Firouzi, M., Lin, M. & Sanguinetti, M. C. The S4-S5 linker couples voltage sensing and activation of pacemaker channels. Proc. Natl. Acad. Sci. 98, 11277-11282 (2001).
25. Priebe, L. & Beuckelmann, D. J. Simulation study of cellular electric properties in heart failure. Circ. Res. 82, 1206-1223 (1998).
26. ten Tusscher, K. H., Noble, D., Noble, P. J. & Panfilov, A. V. A model for human ventricular tissue. Am. J. Physiol. Heart Circ. Physiol. 286, H1573-H1589 (2004).
27. Luo, C. H. & Rudy, Y. A dynamic model of the cardiac ventricular action potential: I. Simulations of ionic currents and concentration changes. Circ. Res. 74, 1071-1096 (1994).
28. Cerbai, E., Sartiani, L., de Paoli, P., Pino, R., Maccherini, M., Bizzarri, F. et al. The properties of the pacemaker current I(F)in human ventricular myocytes are modulated by cardiac disease. J. Mol. Cell. Cardiol. 33, 441-448 (2001).
29. Kaupp, U. B. & Seifert, R. Molecular diversity of pacemaker ion channels. Annu. Rev. Physiol. 63, 235-257 (2001).
30. Brugada, P., Geelen, P., Brugada, R., Mont, L. & Brugada, J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J. Cardiovasc. Electrophysiol. 12, 1004-1007 (2001).